RIPK2 inhibition gets the NOD for asthma

IF 16.6 1区 医学 Q1 RESPIRATORY SYSTEM European Respiratory Journal Pub Date : 2024-10-03 DOI:10.1183/13993003.01372-2024
Henry J. McSorley
{"title":"RIPK2 inhibition gets the NOD for asthma","authors":"Henry J. McSorley","doi":"10.1183/13993003.01372-2024","DOIUrl":null,"url":null,"abstract":"<sec><st>Extract</st>\n<p>Asthma is a common disease affecting around 300 million people worldwide [1]. It is associated with airway remodelling, smooth muscle hypercontractility and increased mucus production, all of which can cause reduced lung function, reversible airway obstruction and characteristic wheeze.</p>\n</sec>","PeriodicalId":12265,"journal":{"name":"European Respiratory Journal","volume":"26 1","pages":""},"PeriodicalIF":16.6000,"publicationDate":"2024-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Respiratory Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1183/13993003.01372-2024","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

Abstract

Extract

Asthma is a common disease affecting around 300 million people worldwide [1]. It is associated with airway remodelling, smooth muscle hypercontractility and increased mucus production, all of which can cause reduced lung function, reversible airway obstruction and characteristic wheeze.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
抑制 RIPK2 可获得治疗哮喘的 NOD
提取物 哮喘是一种常见疾病,影响着全球约 3 亿人[1]。它与气道重塑、平滑肌收缩力亢进和粘液分泌增加有关,所有这些都会导致肺功能下降、可逆性气道阻塞和特征性喘息。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
European Respiratory Journal
European Respiratory Journal 医学-呼吸系统
CiteScore
27.50
自引率
3.30%
发文量
345
审稿时长
2-4 weeks
期刊介绍: The European Respiratory Journal (ERJ) is the flagship journal of the European Respiratory Society. It has a current impact factor of 24.9. The journal covers various aspects of adult and paediatric respiratory medicine, including cell biology, epidemiology, immunology, oncology, pathophysiology, imaging, occupational medicine, intensive care, sleep medicine, and thoracic surgery. In addition to original research material, the ERJ publishes editorial commentaries, reviews, short research letters, and correspondence to the editor. The articles are published continuously and collected into 12 monthly issues in two volumes per year.
期刊最新文献
European Respiratory Society guidelines for the diagnosis and management of pulmonary alveolar proteinosis. Impact of the expanded label for elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with no F508del variant in the USA. Determination of loss of chromosome Y in peripheral blood cells in males with idiopathic pulmonary fibrosis. ERJ advances: epigenetic ageing and leveraging DNA methylation in chronic respiratory diseases. Perspective on WHO implementation guidance on TB infection prevention and control.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1